Author Archives: Owen Prior
Kardium announces 1-year PULSAR IDE study results for its PFA device – the Globe® PF System
04/25/2025
Vancouver, BC – April 25, 2025 — Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed field ablation (PFA) device—the Globe PF System. These pivotal findings from the PULSAR IDE study were announced at the Heart Rhythm […]
Kardium receives CE mark for Globe® Mapping and Ablation System
06/30/2020
VANCOUVER, British Columbia – Kardium Inc. has received CE mark approval for its Globe Mapping and Ablation System – the most complete solution for the treatment of atrial fibrillation (AF).
06/30/2020
Kardium® announces successful results from the GLOBAL-AF study
10/08/2019
October 8, 2019 9:00 AM Pacific Standard Time VANCOUVER, British Columbia — Kardium Inc. today announced that the Globe® Mapping and Ablation System has successfully demonstrated safety and efficacy in the GLOBAL-AF study. The results of the study were published in the Journal of Cardiovascular Electrophysiology. The study demonstrated a 76% percent freedom from atrial […]
09/01/2019
01/24/2019
T. Rowe Price leads new round of financing together with new and existing investors January 24 2019 10:00 AM Pacific Standard Time VANCOUVER, B.C. – Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, announced today that it has raised an undisclosed amount in a new financing round. […]